Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.

Although progress was made in in vitro fertilization (IVF) techniques, the majority of embryos transferred fail to implant. Morphology embryo scoring is the standard procedure for most of IVF centres for choosing the best embryo, but remains limited since even the embryos classified as "top qua...

Full description

Bibliographic Details
Main Authors: Sylvie Bouvier, Odile Paulmyer-Lacroix, Nicolas Molinari, Alexandrine Bertaud, Marine Paci, Aurélie Leroyer, Stéphane Robert, Françoise Dignat George, Marcel Blot-Chabaud, Nathalie Bardin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5349662?pdf=render
_version_ 1818305664973275136
author Sylvie Bouvier
Odile Paulmyer-Lacroix
Nicolas Molinari
Alexandrine Bertaud
Marine Paci
Aurélie Leroyer
Stéphane Robert
Françoise Dignat George
Marcel Blot-Chabaud
Nathalie Bardin
author_facet Sylvie Bouvier
Odile Paulmyer-Lacroix
Nicolas Molinari
Alexandrine Bertaud
Marine Paci
Aurélie Leroyer
Stéphane Robert
Françoise Dignat George
Marcel Blot-Chabaud
Nathalie Bardin
author_sort Sylvie Bouvier
collection DOAJ
description Although progress was made in in vitro fertilization (IVF) techniques, the majority of embryos transferred fail to implant. Morphology embryo scoring is the standard procedure for most of IVF centres for choosing the best embryo, but remains limited since even the embryos classified as "top quality" may not implant. As it has been shown that i) CD146 is involved in embryo implantation and ii) membrane form is shed to generate soluble CD146 (sCD146), we propose that sCD146 in embryo supernatants may constitute a new biomarker of embryo selection. Immunocytochemical staining showed expression of CD146 in early embryo stages and sCD146 was detected by ELISA and Western-blot in embryo supernatants from D2. We retrospectively studied 126 couples who underwent IVF attempt. The embryo culture medium from each transferred embryo (n = 222) was collected for measurement of sCD146 by ELISA. Significantly higher sCD146 concentrations were present in embryo supernatants that did not implant (n = 185) as compared to those that successfully implanted (n = 37) (1310 +/- 1152 pg.mL-1 vs. 845+/- 1173 pg.mL-1, p = 0.024). Sensitivity analysis performed on single embryo transfers (n = 71) confirmed this association (p = 0.0054). The computed ROC curve established that the optimal sCD146 concentration for embryo implantation is under 1164 pg.mL-1 (sensitivity: 76%, specificity: 48%, PPV: 25% and NPV: 92%). Over this sCD146 threshold, the implantation rate was significantly lower (9% with sCD146 levels >1164 pg.ml-1 vs. 22% with sCD146 levels ≤ 1164 pg.mL-1, p = 0.01). Among the embryos preselected by morphologic scoring, sCD146 determination could allow a better selection of the embryo(s), thus improving the success of elective single embryo transfer. This study establishes the proof of concept for the use of sCD146 as a biomarker for IVF by excluding the embryo with the highest sCD146 level. A multicentre prospective study will now be necessary to further establish its use in clinical practice.
first_indexed 2024-12-13T06:30:12Z
format Article
id doaj.art-036df920105d45af91cfc8ef10fe86b8
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T06:30:12Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-036df920105d45af91cfc8ef10fe86b82022-12-21T23:56:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01123e017372410.1371/journal.pone.0173724Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.Sylvie BouvierOdile Paulmyer-LacroixNicolas MolinariAlexandrine BertaudMarine PaciAurélie LeroyerStéphane RobertFrançoise Dignat GeorgeMarcel Blot-ChabaudNathalie BardinAlthough progress was made in in vitro fertilization (IVF) techniques, the majority of embryos transferred fail to implant. Morphology embryo scoring is the standard procedure for most of IVF centres for choosing the best embryo, but remains limited since even the embryos classified as "top quality" may not implant. As it has been shown that i) CD146 is involved in embryo implantation and ii) membrane form is shed to generate soluble CD146 (sCD146), we propose that sCD146 in embryo supernatants may constitute a new biomarker of embryo selection. Immunocytochemical staining showed expression of CD146 in early embryo stages and sCD146 was detected by ELISA and Western-blot in embryo supernatants from D2. We retrospectively studied 126 couples who underwent IVF attempt. The embryo culture medium from each transferred embryo (n = 222) was collected for measurement of sCD146 by ELISA. Significantly higher sCD146 concentrations were present in embryo supernatants that did not implant (n = 185) as compared to those that successfully implanted (n = 37) (1310 +/- 1152 pg.mL-1 vs. 845+/- 1173 pg.mL-1, p = 0.024). Sensitivity analysis performed on single embryo transfers (n = 71) confirmed this association (p = 0.0054). The computed ROC curve established that the optimal sCD146 concentration for embryo implantation is under 1164 pg.mL-1 (sensitivity: 76%, specificity: 48%, PPV: 25% and NPV: 92%). Over this sCD146 threshold, the implantation rate was significantly lower (9% with sCD146 levels >1164 pg.ml-1 vs. 22% with sCD146 levels ≤ 1164 pg.mL-1, p = 0.01). Among the embryos preselected by morphologic scoring, sCD146 determination could allow a better selection of the embryo(s), thus improving the success of elective single embryo transfer. This study establishes the proof of concept for the use of sCD146 as a biomarker for IVF by excluding the embryo with the highest sCD146 level. A multicentre prospective study will now be necessary to further establish its use in clinical practice.http://europepmc.org/articles/PMC5349662?pdf=render
spellingShingle Sylvie Bouvier
Odile Paulmyer-Lacroix
Nicolas Molinari
Alexandrine Bertaud
Marine Paci
Aurélie Leroyer
Stéphane Robert
Françoise Dignat George
Marcel Blot-Chabaud
Nathalie Bardin
Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.
PLoS ONE
title Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.
title_full Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.
title_fullStr Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.
title_full_unstemmed Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.
title_short Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.
title_sort soluble cd146 an innovative and non invasive biomarker of embryo selection for in vitro fertilization
url http://europepmc.org/articles/PMC5349662?pdf=render
work_keys_str_mv AT sylviebouvier solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization
AT odilepaulmyerlacroix solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization
AT nicolasmolinari solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization
AT alexandrinebertaud solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization
AT marinepaci solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization
AT aurelieleroyer solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization
AT stephanerobert solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization
AT francoisedignatgeorge solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization
AT marcelblotchabaud solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization
AT nathaliebardin solublecd146aninnovativeandnoninvasivebiomarkerofembryoselectionforinvitrofertilization